西亚试剂:A novel strategy to develop robust infectious hepatitis C v
发布时间:2025-12-18
A novel strategy to develop robust infectious hepatitis C virus cell culture system directly from a clinical isolate
Jie Lu1, Yu Xiang1, Wanyin Tao1, Qingchao Li1, Na Wang1, Yongfeng Gao1, Xiaogang Xiang2, Qing Xie2 and Jin Zhong1
HCV infection is a leading cause of chronic liver diseases. The progress in HCV field was greatly enhanced by constructing infectious cDNA clone of JFH-1. Since then, JFH-1-based intra- and inter-genotypic recombinants were developed and allowed the study of vaccines and antiviral inhibitors for all genotypes. Only until recently, highly efficient HCV culture systems have been established by using consensus sequence-based clones. In this study, we developed a novel strategy to construct infectious HCV cDNA clone by combining functional screening of sequences directly from a genotype 2a clinical isolate (PR63) and cell culture adaptation. Using JFH-1 cDNA as the starting backbone, we sequentially replaced the JFH-1 fragments with a sequence from the pools of PR63 sequences. Through engineering adaptive mutations that improve HCV infectivity, we finally established a full-length cell culture-derived infectious clone of PR63, named PR63cc, which could efficiently produce virus particles in Huh7 derived cells, with peak titers of 1.6×105 ffu/mL. The PR63cc could be neutralized by an anti-E2 antibody and inhibited by antiviral agents, but appeared more resistant to an NS5A inhibitor than JFH-1. In summary: we developed a new approach to construct infectious HCV cDNA clone that can produce viruses efficiently in cell culture. This approach could be applied to other viral isolates, with potential implications for individualized treatments of HCV patients.
- 以上资料由西亚试剂:http://www.xiyashiji.com/ 提供此产品的详细信息如密度,含量,分子式,分子量等均可在西亚官网查询
- 相关产品如溴化汞硝酸亚汞氯化亚汞乙酸苯汞氯化钾汞 碘化汞钾硫氰酸汞硫酸亚汞氧化汞氯化汞碘化汞硝酸汞三氯氧磷三氯化磷碘甲烷二碘甲烷三碘甲烷三氟碘甲烷氘代碘甲烷碘乙烷1,2-二碘乙烷甲酸铷碘化铷溴化铷铬酸铷硫酸铷氟化铷硝酸铷氯化铷碳酸铷硫酸镱 碳酸镱氯化镱硝酸镱氧化镱等均有销售.欢迎订购
下一篇:西亚试剂:科学家发现新型DNA合成机制 或可解释细胞特殊遗传突变的发生



鲁ICP备20015914号-4